These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 22930424)

  • 1. Evaluation of drug supersaturation by thermodynamic and kinetic approaches for the prediction of oral absorbability in amorphous pharmaceuticals.
    Ozaki S; Kushida I; Yamashita T; Hasebe T; Shirai O; Kano K
    J Pharm Sci; 2012 Nov; 101(11):4220-30. PubMed ID: 22930424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Supersaturation-nucleation behavior of poorly soluble drugs and its impact on the oral absorption of drugs in thermodynamically high-energy forms.
    Ozaki S; Minamisono T; Yamashita T; Kato T; Kushida I
    J Pharm Sci; 2012 Jan; 101(1):214-22. PubMed ID: 21918988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of crystal nucleation and growth by water-soluble polymers and its impact on the supersaturation profiles of amorphous drugs.
    Ozaki S; Kushida I; Yamashita T; Hasebe T; Shirai O; Kano K
    J Pharm Sci; 2013 Jul; 102(7):2273-81. PubMed ID: 23658029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Supersaturation, nucleation, and crystal growth during single- and biphasic dissolution of amorphous solid dispersions: polymer effects and implications for oral bioavailability enhancement of poorly water soluble drugs.
    Sarode AL; Wang P; Obara S; Worthen DR
    Eur J Pharm Biopharm; 2014 Apr; 86(3):351-60. PubMed ID: 24161655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evolution of supersaturation of amorphous pharmaceuticals: the effect of rate of supersaturation generation.
    Sun DD; Lee PI
    Mol Pharm; 2013 Nov; 10(11):4330-46. PubMed ID: 24066837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evolution of supersaturation of amorphous pharmaceuticals: nonlinear rate of supersaturation generation regulated by matrix diffusion.
    Sun DD; Lee PI
    Mol Pharm; 2015 Apr; 12(4):1203-15. PubMed ID: 25775257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro-in vivo correlation of the effect of supersaturation on the intestinal absorption of BCS Class 2 drugs.
    Higashino H; Hasegawa T; Yamamoto M; Matsui R; Masaoka Y; Kataoka M; Sakuma S; Yamashita S
    Mol Pharm; 2014 Mar; 11(3):746-54. PubMed ID: 24460473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of oral absorption of cinnarizine--a highly supersaturating poorly soluble weak base with borderline permeability.
    Berlin M; Przyklenk KH; Richtberg A; Baumann W; Dressman JB
    Eur J Pharm Biopharm; 2014 Nov; 88(3):795-806. PubMed ID: 25195981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative analysis of the effect of supersaturation on in vivo drug absorption.
    Takano R; Takata N; Saito R; Furumoto K; Higo S; Hayashi Y; Machida M; Aso Y; Yamashita S
    Mol Pharm; 2010 Oct; 7(5):1431-40. PubMed ID: 20704264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intestinal bile secretion promotes drug absorption from lipid colloidal phases via induction of supersaturation.
    Yeap YY; Trevaskis NL; Quach T; Tso P; Charman WN; Porter CJ
    Mol Pharm; 2013 May; 10(5):1874-89. PubMed ID: 23480483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thermodynamics of Highly Supersaturated Aqueous Solutions of Poorly Water-Soluble Drugs-Impact of a Second Drug on the Solution Phase Behavior and Implications for Combination Products.
    Trasi NS; Taylor LS
    J Pharm Sci; 2015 Aug; 104(8):2583-93. PubMed ID: 26059413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of the amorphous "solubility" of a group of diverse drugs using new experimental and theoretical approaches.
    Almeida e Sousa L; Reutzel-Edens SM; Stephenson GA; Taylor LS
    Mol Pharm; 2015 Feb; 12(2):484-95. PubMed ID: 25495614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting the Solubility Advantage of Amorphous Pharmaceuticals: A Novel Thermodynamic Approach.
    Paus R; Ji Y; Vahle L; Sadowski G
    Mol Pharm; 2015 Aug; 12(8):2823-33. PubMed ID: 26107071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amorphization strategy affects the stability and supersaturation profile of amorphous drug nanoparticles.
    Cheow WS; Kiew TY; Yang Y; Hadinoto K
    Mol Pharm; 2014 May; 11(5):1611-20. PubMed ID: 24669821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of surfactants, gastric emptying, and dosage form on supersaturation of dipyridamole in an in vitro model simulating the stomach and duodenum.
    Mitra A; Fadda HM
    Mol Pharm; 2014 Aug; 11(8):2835-44. PubMed ID: 25025699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relevance of supersaturation and solubilization in the gastrointestinal tract for oral bioavailability: An in vitro vs. in vivo approach.
    López Mármol Á; Denninger A; Touzet A; Dauer K; Becker T; Pöstges F; Pellequer Y; Lamprecht A; Wagner KG
    Int J Pharm; 2021 Jun; 603():120648. PubMed ID: 33915180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Solubility advantage of amorphous pharmaceuticals, part 3: Is maximum solubility advantage experimentally attainable and sustainable?
    Murdande SB; Pikal MJ; Shanker RM; Bogner RH
    J Pharm Sci; 2011 Oct; 100(10):4349-56. PubMed ID: 21630280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Supersaturated polymeric micelles for oral cyclosporine A delivery.
    Yu H; Xia D; Zhu Q; Zhu C; Chen D; Gan Y
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1325-36. PubMed ID: 23954511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced kinetic solubility profiles of indomethacin amorphous solid dispersions in poly(2-hydroxyethyl methacrylate) hydrogels.
    Sun DD; Ju TC; Lee PI
    Eur J Pharm Biopharm; 2012 May; 81(1):149-58. PubMed ID: 22233548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The potential for drug supersaturation during intestinal processing of lipid-based formulations may be enhanced for basic drugs.
    Yeap YY; Trevaskis NL; Porter CJ
    Mol Pharm; 2013 Jul; 10(7):2601-15. PubMed ID: 23697606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.